Market Closed -
Bombay S.E.
06:24:55 2024-05-21 EDT
|
5-day change
|
1st Jan Change
|
3.91
INR
|
-1.01%
|
|
+2.62%
|
+6.54%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8,229
|
3,182
|
310.7
|
635.4
|
4,962
|
2,371
|
Enterprise Value (EV)
1 |
9,610
|
4,751
|
1,775
|
2,145
|
5,863
|
2,987
|
P/E ratio
|
28.8
x
|
19.4
x
|
30.5
x
|
-4.43
x
|
358
x
|
25
x
|
Yield
|
0.17%
|
0.44%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.28
x
|
1.3
x
|
0.16
x
|
0.53
x
|
1.98
x
|
0.59
x
|
EV / Revenue
|
2.66
x
|
1.93
x
|
0.89
x
|
1.81
x
|
2.34
x
|
0.74
x
|
EV / EBITDA
|
16.3
x
|
11.4
x
|
8.29
x
|
27.8
x
|
24.1
x
|
12.1
x
|
EV / FCF
|
-28.7
x
|
-22.7
x
|
31.2
x
|
48.6
x
|
-17.8
x
|
4.23
x
|
FCF Yield
|
-3.49%
|
-4.41%
|
3.21%
|
2.06%
|
-5.61%
|
23.6%
|
Price to Book
|
5.15
x
|
2.22
x
|
0.22
x
|
0.49
x
|
2.19
x
|
1
x
|
Nbr of stocks (in thousands)
|
279,900
|
279,900
|
279,900
|
279,900
|
934,393
|
948,576
|
Reference price
2 |
29.40
|
11.37
|
1.110
|
2.270
|
5.310
|
2.500
|
Announcement Date
|
18-09-11
|
19-09-06
|
20-09-07
|
21-09-04
|
22-09-22
|
23-09-05
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,616
|
2,457
|
1,992
|
1,188
|
2,504
|
4,045
|
EBITDA
1 |
587.8
|
417
|
214.2
|
77.23
|
243.3
|
246.5
|
EBIT
1 |
549.4
|
369.3
|
166.5
|
37.6
|
207.3
|
211.5
|
Operating Margin
|
15.19%
|
15.03%
|
8.36%
|
3.16%
|
8.28%
|
5.23%
|
Earnings before Tax (EBT)
1 |
436.2
|
231.9
|
28.84
|
-130.7
|
20.95
|
104.9
|
Net income
1 |
286.1
|
163.8
|
10.18
|
-143.5
|
13.92
|
95.27
|
Net margin
|
7.91%
|
6.67%
|
0.51%
|
-12.08%
|
0.56%
|
2.36%
|
EPS
2 |
1.020
|
0.5851
|
0.0364
|
-0.5127
|
0.0148
|
0.1000
|
Free Cash Flow
1 |
-335
|
-209.7
|
56.91
|
44.17
|
-329.2
|
705.5
|
FCF margin
|
-9.26%
|
-8.54%
|
2.86%
|
3.72%
|
-13.15%
|
17.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
26.58%
|
57.19%
|
-
|
286.21%
|
FCF Conversion (Net income)
|
-
|
-
|
558.95%
|
-
|
-
|
740.53%
|
Dividend per Share
2 |
0.0500
|
0.0500
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-09-11
|
19-09-06
|
20-09-07
|
21-09-04
|
22-09-22
|
23-09-05
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,381
|
1,568
|
1,464
|
1,510
|
901
|
616
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.349
x
|
3.761
x
|
6.838
x
|
19.55
x
|
3.705
x
|
2.498
x
|
Free Cash Flow
1 |
-335
|
-210
|
56.9
|
44.2
|
-329
|
706
|
ROE (net income / shareholders' equity)
|
19.5%
|
12.1%
|
0.71%
|
-10.6%
|
0.78%
|
4.09%
|
ROA (Net income/ Total Assets)
|
9.7%
|
6.53%
|
2.83%
|
0.7%
|
3.87%
|
3.85%
|
Assets
1 |
2,950
|
2,507
|
360.3
|
-20,494
|
360.1
|
2,475
|
Book Value Per Share
2 |
5.710
|
5.120
|
5.110
|
4.600
|
2.420
|
2.510
|
Cash Flow per Share
2 |
0.1200
|
0.0200
|
0.0100
|
0.0100
|
0.0300
|
0
|
Capex
1 |
116
|
177
|
2.47
|
10.6
|
17.1
|
50.1
|
Capex / Sales
|
3.22%
|
7.2%
|
0.12%
|
0.89%
|
0.68%
|
1.24%
|
Announcement Date
|
18-09-11
|
19-09-06
|
20-09-07
|
21-09-04
|
22-09-22
|
23-09-05
|
|
1st Jan change
|
Capi.
|
---|
| +6.54% | 83.87M | | +18.32% | 67.02B | | +3.32% | 49.69B | | +19.80% | 42.41B | | +23.39% | 26.65B | | +12.19% | 19.62B | | +0.75% | 17.1B | | +3.32% | 15.64B | | -24.51% | 15.43B | | -9.92% | 15.3B |
Other Specialty Chemicals
|